Cite

HARVARD Citation

    Palmerini, E. et al. (2016). Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone. BMC cancer. 16 (1), pp. 1-8. [Online]. 
  
Back to record